Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
0.190
+0.027 (16.78%)
At close: Nov 20, 2024, 4:00 PM
0.167
-0.023 (-12.11%)
Pre-market: Nov 21, 2024, 5:50 AM EST
TNXP Employees
Tonix Pharmaceuticals Holding had 103 employees as of December 31, 2023. The number of employees decreased by 14 or -11.97% compared to the previous year.
Employees
103
Change (1Y)
-14
Growth (1Y)
-11.97%
Revenue / Employee
$109,621
Profits / Employee
-$1,313,107
Market Cap
33.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Allurion Technologies | 504 |
Bionano Genomics | 344 |
BioXcel Therapeutics | 74 |
Enlivex Therapeutics | 71 |
Inspira Technologies Oxy B.H.N. | 42 |
NeuroSense Therapeutics | 18 |
Tempest Therapeutics | 17 |
XTL Biopharmaceuticals | 7 |
TNXP News
- 3 hours ago - Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed - GlobeNewsWire
- 2 days ago - Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual - GlobeNewsWire
- 7 days ago - Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments - Accesswire
- 7 days ago - Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting - GlobeNewsWire
- 7 days ago - Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals - GlobeNewsWire
- 20 days ago - Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024 - GlobeNewsWire
- 23 days ago - Tonix Pharmaceuticals to Present at BIO-Europe® 2024 - GlobeNewsWire
- 27 days ago - Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference - GlobeNewsWire